BILLIONTOONE INC CL A (BLLN) Fundamental Analysis & Valuation

NASDAQ:BLLN • US0901681058

Current stock price

73.74 USD
+2.47 (+3.47%)
Last:

This BLLN fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.

3

1. BLLN Profitability Analysis

1.1 Basic Checks

  • BLLN had positive earnings in the past year.
BLLN Yearly Net Income VS EBIT VS OCF VS FCFBLLN Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2023 2024 2025 0 -20M -40M -60M -80M

1.2 Ratios

  • BLLN has a Return On Assets (0.89%) which is comparable to the rest of the industry.
  • With a Return On Equity value of 1.62%, BLLN perfoms like the industry average, outperforming 56.44% of the companies in the same industry.
  • BLLN has a Return On Invested Capital (4.41%) which is comparable to the rest of the industry.
Industry RankSector Rank
ROA 0.89%
ROE 1.62%
ROIC 4.41%
ROA(3y)-18.81%
ROA(5y)N/A
ROE(3y)-98.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
BLLN Yearly ROA, ROE, ROICBLLN Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2023 2024 2025 0 -50 -100 -150 -200 -250

1.3 Margins

  • BLLN has a Profit Margin (0.96%) which is in line with its industry peers.
  • BLLN has a Operating Margin of 5.25%. This is in the better half of the industry: BLLN outperforms 65.35% of its industry peers.
  • With an excellent Gross Margin value of 68.32%, BLLN belongs to the best of the industry, outperforming 86.14% of the companies in the same industry.
Industry RankSector Rank
OM 5.25%
PM (TTM) 0.96%
GM 68.32%
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
BLLN Yearly Profit, Operating, Gross MarginsBLLN Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2023 2024 2025 0 50 -50 -100

More info and screens

ROAROEROICOperating and Profit MarginShow most profitable peers

7

2. BLLN Health Analysis

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so BLLN is destroying value.
  • Compared to 1 year ago, BLLN has less shares outstanding
  • Compared to 1 year ago, BLLN has an improved debt to assets ratio.
BLLN Yearly Shares OutstandingBLLN Yearly Shares OutstandingYearly Shares Outstanding 2023 2024 2025 10M 20M 30M 40M
BLLN Yearly Total Debt VS Total AssetsBLLN Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2023 2024 2025 200M 400M 600M

2.2 Solvency

  • BLLN has an Altman-Z score of 13.92. This indicates that BLLN is financially healthy and has little risk of bankruptcy at the moment.
  • With an excellent Altman-Z score value of 13.92, BLLN belongs to the best of the industry, outperforming 98.02% of the companies in the same industry.
  • A Debt/Equity ratio of 0.31 indicates that BLLN is not too dependend on debt financing.
  • BLLN has a better Debt to Equity ratio (0.31) than 66.34% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Altman-Z 13.92
ROIC/WACC0.5
WACC8.75%
BLLN Yearly LT Debt VS Equity VS FCFBLLN Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2023 2024 2025 0 100M 200M 300M 400M

2.3 Liquidity

  • BLLN has a Current Ratio of 6.17. This indicates that BLLN is financially healthy and has no problem in meeting its short term obligations.
  • BLLN has a Current ratio of 6.17. This is amongst the best in the industry. BLLN outperforms 95.05% of its industry peers.
  • BLLN has a Quick Ratio of 5.75. This indicates that BLLN is financially healthy and has no problem in meeting its short term obligations.
  • BLLN's Quick ratio of 5.75 is amongst the best of the industry. BLLN outperforms 95.05% of its industry peers.
Industry RankSector Rank
Current Ratio 6.17
Quick Ratio 5.75
BLLN Yearly Current Assets VS Current LiabilitesBLLN Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2023 2024 2025 100M 200M 300M 400M 500M

More info and screens

WACCDebt/EquityHow to determine the health of a companyAltman-Z scoreShow peers with great health

5

3. BLLN Growth Analysis

3.1 Past

  • BLLN shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.79%, which is quite impressive.
  • BLLN shows a strong growth in Revenue. In the last year, the Revenue has grown by 99.97%.
EPS 1Y (TTM)114.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.06%
Revenue 1Y (TTM)99.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-37.05%

3.2 Future

  • Based on estimates for the next years, BLLN will show a very strong growth in Earnings Per Share. The EPS will grow by 131.89% on average per year.
  • The Revenue is expected to grow by 34.51% on average over the next years. This is a very strong growth
EPS Next Y76.15%
EPS Next 2Y131.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year36.76%
Revenue Next 2Y34.51%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

BLLN Yearly Revenue VS EstimatesBLLN Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2023 2024 2025 2026 2027 100M 200M 300M 400M 500M
BLLN Yearly EPS VS EstimatesBLLN Yearly EPS VS EstimatesYearly EPS VS Estimates 2025 2026 2027 0.2 0.4 0.6 0.8

More info and screens

Find the best growth stocksShow best growing peers

1

4. BLLN Valuation Analysis

4.1 Price/Earnings Ratio

  • The Price/Earnings ratio is 526.71, which means the current valuation is very expensive for BLLN.
  • BLLN's Price/Earnings ratio is a bit more expensive when compared to the industry. BLLN is more expensive than 60.40% of the companies in the same industry.
  • The average S&P500 Price/Earnings ratio is at 25.79. BLLN is valued rather expensively when compared to this.
  • Based on the Price/Forward Earnings ratio of 256.70, the valuation of BLLN can be described as expensive.
  • BLLN's Price/Forward Earnings ratio is a bit more expensive when compared to the industry. BLLN is more expensive than 63.37% of the companies in the same industry.
  • BLLN's Price/Forward Earnings ratio indicates a rather expensive valuation when compared to the S&P500 average which is at 23.80.
Industry RankSector Rank
PE 526.71
Fwd PE 256.7
BLLN Price Earnings VS Forward Price EarningsBLLN Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 100 200 300 400 500

4.2 Price Multiples

Industry RankSector Rank
P/FCF N/A
EV/EBITDA N/A
BLLN Per share dataBLLN EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 2 4 6

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates BLLN does not grow enough to justify the current Price/Earnings ratio.
  • A more expensive valuation may be justified as BLLN's earnings are expected to grow with 131.89% in the coming years.
PEG (NY)6.92
PEG (5Y)N/A
EPS Next 2Y131.89%
EPS Next 3YN/A

More info and screens

Price/EarningsPrice/FCFFCF per shareEV/EBITDAPEG RATIOShow best valued peers

0

5. BLLN Dividend Analysis

5.1 Amount

  • BLLN does not give a dividend.
Industry RankSector Rank
Dividend Yield 0%

More info and screens

Find the best dividend stocksShow peers with best dividend

BLLN Fundamentals: All Metrics, Ratios and Statistics

BILLIONTOONE INC CL A

NASDAQ:BLLN (3/19/2026, 3:54:37 PM)

73.74

+2.47 (+3.47%)

Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)03-04
Earnings (Next)N/A
Inst Owners27.93%
Inst Owner Change37346.8%
Ins Owners19.2%
Ins Owner Change-43.63%
Market Cap3.38B
Revenue(TTM)305.11M
Net Income(TTM)2.92M
Analysts84.29
Price Target137.99 (87.13%)
Short Float %5.82%
Short Ratio4.2
Dividend
Industry RankSector Rank
Dividend Yield 0%
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr YearsN/A
Div Non Decr YearsN/A
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0%
PT rev (3m)N/A
EPS NQ rev (1m)0%
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)N/A
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)N/A
Valuation
Industry RankSector Rank
PE 526.71
Fwd PE 256.7
P/S 11.06
P/FCF N/A
P/OCF N/A
P/B 18.76
P/tB 18.76
EV/EBITDA N/A
EPS(TTM)0.14
EY0.19%
EPS(NY)0.29
Fwd EY0.39%
FCF(TTM)N/A
FCFYN/A
OCF(TTM)N/A
OCFYN/A
SpS6.67
BVpS3.93
TBVpS3.93
PEG (NY)6.92
PEG (5Y)N/A
Graham Number3.52
Profitability
Industry RankSector Rank
ROA 0.89%
ROE 1.62%
ROCE 5.59%
ROIC 4.41%
ROICexc 13.82%
ROICexgc 13.82%
OM 5.25%
PM (TTM) 0.96%
GM 68.32%
FCFM N/A
ROA(3y)-18.81%
ROA(5y)N/A
ROE(3y)-98.5%
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3YN/A
GM growth 5YN/A
F-ScoreN/A
Asset Turnover0.93
Health
Industry RankSector Rank
Debt/Equity 0.31
Debt/FCF N/A
Debt/EBITDA N/A
Cap/Depr N/A
Cap/Sales N/A
Interest Coverage N/A
Cash Conversion N/A
Profit Quality N/A
Current Ratio 6.17
Quick Ratio 5.75
Altman-Z 13.92
F-ScoreN/A
WACC8.75%
ROIC/WACC0.5
Cap/Depr(3y)N/A
Cap/Depr(5y)N/A
Cap/Sales(3y)N/A
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.79%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%112.06%
EPS Next Y76.15%
EPS Next 2Y131.89%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)99.97%
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%-37.05%
Revenue Next Year36.76%
Revenue Next 2Y34.51%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y133.99%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year406.34%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1YN/A
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1YN/A
OCF growth 3YN/A
OCF growth 5YN/A

BILLIONTOONE INC CL A / BLLN Fundamental Analysis FAQ

What is the ChartMill fundamental rating of BILLIONTOONE INC CL A (BLLN) stock?

ChartMill assigns a fundamental rating of 4 / 10 to BLLN.


What is the valuation status for BLLN stock?

ChartMill assigns a valuation rating of 1 / 10 to BILLIONTOONE INC CL A (BLLN). This can be considered as Overvalued.


How profitable is BILLIONTOONE INC CL A (BLLN) stock?

BILLIONTOONE INC CL A (BLLN) has a profitability rating of 3 / 10.


What is the valuation of BILLIONTOONE INC CL A based on its PE and PB ratios?

The Price/Earnings (PE) ratio for BILLIONTOONE INC CL A (BLLN) is 526.71 and the Price/Book (PB) ratio is 18.76.